MeSsAGe Risk Score: Tool for Renal Biopsy Decision in Steroid-dependent Nephrotic Syndrome

MeSsAGe Risk Score: Tool for Renal Biopsy Decision in Steroid-dependent Nephrotic Syndrome
Title:
MeSsAGe Risk Score: Tool for Renal Biopsy Decision in Steroid-dependent Nephrotic Syndrome
Other Titles:
Pediatric Research
Keywords:
Publication Date:
15 January 2019
Citation:
Pediatr Res. 2019 Mar;85(4):477-483
Abstract:
Background: A lack of consensus exists as to the timing of kidney biopsy in children with steroid-dependent nephrotic syndrome (SDNS) where minimal change disease (MCD) predominates. This study aimed at examining the applicability of a biomarker-assisted risk score model to select SDNS patients at high risk of focal segmental glomerulosclerosis (FSGS) for biopsy. Methods: Fifty-five patients with SDNS and biopsy-proven MCD (n=40) or FSGS (n=15), were studied. A risk score model was developed with variables consisting of age, sex, eGFR, suPAR levels and percent CD8+ memory T-cells. Following multivariate regression analysis, total risk score was calculated as sum of the products of odds ratios and corresponding variables. Predictive cut-off point was determined using receiver operator characteristics (ROC) curve analysis. Results: Plasma suPAR levels in FSGS patients were significantly higher, while percent CD45RO+CD8+CD3+ was significantly lower than MCD patients and controls. ROC analysis suggests the risk score model with threshold score of 16.7 (AUC 0.84, 95%CI 0.72-0.96) was a good predictor of FSGS on biopsy. The 100% PPV cut-off was >24.0, while the 100% NPV was <13.3. Conclusion : A suPAR and CD8+ memory T-cells percentage based risk score model was developed to stratify SDNS patients for biopsy and for predicting FSGS.
License type:
PublisherCopyrights
Funding Info:
This work was supported by grants from the Singapore Immunology Network (SIgN) and the National Medical Research Council (NMRC), Singapore.
Description:
ISSN:
0031-3998
1530-0447
Files uploaded: